Stocks · Health care · Pharmaceutical Preparations

Dermata Therapeutics, Inc.

DRMA Clue Score42
United States Fiscal year ends December CIK 0001853816 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Munera Maria E Bedoya-Toro
17 Feb 2026
SVP, Regulatory Affairs
Buy
1,000
$1.27
$1.27K
Gerald T Proehl
23 Nov 2021
President, CEO and Chairman
Buy
20,000
$2.40
$48.00K
Gerald T Proehl
17 Aug 2021
President, CEO and Chairman
Buy indirect
142,857
—
no price
David F Hale
17 Aug 2021
Director
Buy indirect
35,714
—
no price
Gerald T Proehl
16 Aug 2021
President, CEO and Chairman
Buy indirect
10,000
$4.96
$49.63K

What was left out

Form 4 filings counted 89
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 2
Shares from compensation/vesting 6,765,882
History held since 17 Aug 2021